Showing results (21-30 of 107) with videos related to
Sort By:
Pageof 11
The Journal of Dermatology|October 25, 2022
Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double-blind, placebo-controlled Effisayil™ 1 studyAkimichi Morita, Tsen-Fang Tsai, Evelyn Yap Wen Yee, et al.Cancer|March 15, 2006
Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infectionLaurence Fardet, Pierre-Emmanuel Stoebner, Herve Bachelez, et al.The British Journal of Dermatology|May 10, 2023
Incidence and prevalence of generalized pustular psoriasis in multiethnic Johor Bahru, Malaysia: a population-based cohort study using routinely captured electronic health records in the Teleprimary Care (TPC®) clinical information system from 2010 to 2020Siew Eng Choon, Alison K Wright, Christopher E M Griffiths, et al.The British Journal of Dermatology|July 13, 2022
Incidence and prevalence of psoriasis in multiethnic Johor Bahru, Malaysia: a population-based cohort study using electronic health data routinely captured in the Teleprimary Care (TPC®) clinical information system from 2010 to 2020: Classification: EpidemiologySiew Eng Choon, Alison K Wright, Christopher E M Griffiths, et al.Dermatology and Therapy|February 10, 2025
Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological ConditionsKenneth B Gordon, Yayoi Tada, Milan J Anadkat, et al.Dermatology and Therapy|November 5, 2022
Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular PsoriasisAkimichi Morita, Siew Eng Choon, Hervé Bachelez, et al.The British Journal of Dermatology|January 23, 2025
Global Delphi consensus on treatment goals for generalized pustular psoriasisJonathan N Barker, Emmylou Casanova, Siew Eng Choon, et al.Journal of the American Academy of Dermatology|March 15, 2017
Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III studyKim Papp, Herve Bachelez, Antonio Costanzo, et al.Archives of Dermatological Research|October 6, 2006
The importance of disease associations and concomitant therapy for the long-term management of psoriasis patientsUlrich Mrowietz, James T Elder, Jonathan BarkerJAMA Dermatology|April 6, 2013
Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional studyAmy S Paller, Katherine Mercy, Mary J Kwasny, et al.Pageof 11